IDH1 and glioblastoma: To test this hypothesis, we treated isogenic pairs of murine Ink4a-Arf−/− EGFRvIII glioblastoma lines expressing either IDH1-R132H or wild type IDH1 with the EGFR inhibitor, Gefitinib [41].